ARCHIVES

Advocates Oppose Proposals to Market Drugs After Phase I.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Adcetris Granted Approval For Hodgkin’s Lymphoma and ALCL

September 30, 2011

In Brief: Krakoff To Head New M.D. Anderson Division, Two Other Appointments Made In Reorganization There

July 22, 1983

Sen. Specter Seeks NCI Explanation of Delay in P-4 Breast Cancer Prevention Trial.

May 25, 2007

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

March 14, 2008

NIH Changes SBIR/STTG Application Receipt Dates.

February 18, 2000

In Brief: William Paul to Head AIDS Research Officer; Schachman Is NIH Extramural Obudsman

February 25, 1994